glp 1 boom GLP-1 Boom: US/UK Restaurants & Supermarkets Roll Out Ozempic-Friendly Food GLP-1 rush: Pharma, food firms
Description
European regulators have already classified NAION as a very rare adverse effect of semaglutide
Explore the pros and cons of GLP-1 medications for managing type 2 diabetes and weight loss.
Jacqueline Cooper, IBCLC
These blockbuster therapies are clear indicators of where innovation and market momentum are heading in 2025
For retailers and CPG brands, the challenge and opportunity lies in meeting these consumers precisely where they are along the weight-loss journey, engagin
